Date published: 2026-5-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

17(S)-HpDoHE (CAS 123673-33-6)

0.0(0)
Write a reviewAsk a question

Alternate Names:
17(S)-hydroperoxy Docosahexaenoic Acid; 17(S)-HpDHA
CAS Number:
123673-33-6
Molecular Weight:
360.5
Molecular Formula:
C22H32O4
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

17(S)-HpDoHE, with the CAS number 123673-33-6, is a hydroxyperoxy derivative of docosahexaenoic acid (DHA), an omega-3 fatty acid prominent in neural and cardiovascular physiology. This compound is specifically a hydroperoxide formed by the lipoxygenase-mediated oxygenation of DHA at the 17th carbon, resulting in the formation of a hydroperoxy group. As a potent signaling molecule, 17(S)-HpDoHE has been utilized extensively in research to understand the complex mechanisms of lipid signaling in cellular environments. It plays a critical role in the modulation of inflammation and oxidative stress responses within cells. In cellular studies, 17(S)-HpDoHE has been observed to influence signaling pathways that regulate inflammatory mediators, potentially impacting the cellular response to oxidative damage and contributing to the regulation of cellular defense mechanisms. Research employing this molecule focuses on its capacity to act as a precursor to other bioactive metabolites and its direct involvement in signaling pathways that control cellular responses to environmental stimuli. By studying 17(S)-HpDoHE, researchers gain insights into the broader roles of oxidized lipid derivatives in cellular communication, particularly in contexts where oxidative stress and inflammation are prevalent, providing a deeper understanding of the dynamics of lipid-mediated cellular processes.


17(S)-HpDoHE (CAS 123673-33-6) References

  1. DHA metabolism: targeting the brain and lipoxygenation.  |  Picq, M., et al. 2010. Mol Neurobiol. 42: 48-51. PMID: 20422316
  2. Lipid mediator profiling in pulmonary disease.  |  Lundström, SL., et al. 2011. Curr Pharm Biotechnol. 12: 1026-52. PMID: 21466458
  3. Unesterified docosahexaenoic acid is protective in neuroinflammation.  |  Orr, SK., et al. 2013. J Neurochem. 127: 378-93. PMID: 23919613
  4. Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome.  |  Marette, A., et al. 2014. Rev Endocr Metab Disord. 15: 299-305. PMID: 25326656
  5. Emerging roles of pro-resolving lipid mediators in immunological and adaptive responses to exercise-induced muscle injury.  |  Markworth, JF., et al. 2016. Exerc Immunol Rev. 22: 110-34. PMID: 26853678
  6. The Biosynthesis of Enzymatically Oxidized Lipids.  |  Hajeyah, AA., et al. 2020. Front Endocrinol (Lausanne). 11: 591819. PMID: 33329396
  7. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.  |  Hachem, M. 2021. Biochimie. 184: 95-103. PMID: 33639198
  8. In Vitro Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2.  |  Tsai, WC., et al. 2021. Biochemistry. 60: 1741-1754. PMID: 34029049
  9. Molecular insights into lipoxygenases for biocatalytic synthesis of diverse lipid mediators.  |  An, JU., et al. 2021. Prog Lipid Res. 83: 101110. PMID: 34144023

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

17(S)-HpDoHE, 25 µg

sc-220655
25 µg
$122.00

17(S)-HpDoHE, 50 µg

sc-220655A
50 µg
$233.00